Bovine respiratory syncytial virus-specific IgG-1 in nasal secretions of colostrum-fed neonatal calves

In order to determine whether nasal secretions of young calves contain passively derived antibodies to bovine respiratory syncytial virus (BRSV) and if there are differences in presence and/or subclass of these antibodies between calves fed different colostrum replacement products, 17 Holstein calve...

Full description

Saved in:
Bibliographic Details
Published in:Canadian veterinary journal 2018-05, Vol.59 (5), p.505-508
Main Authors: Ellis, John A, Chamorro, Manuel F, Lacoste, Stacey, Gow, Sheryl P, Haines, Deborah M
Format: Article
Language:English
Subjects:
Animal Feed
Animals
Animals, Newborn
Antibodies, Viral - analysis
Antibodies, Viral - metabolism
Antibody Specificity
Cattle - immunology
Colostrum
Humans
Immunity, Maternally-Acquired
Immunoglobulin G - analysis
Immunoglobulin G - metabolism
Male
Mucus
Nasal Cavity - chemistry
Nasal Cavity - metabolism
Respiratory Syncytial Virus, Bovine - immunology
Scientific
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to determine whether nasal secretions of young calves contain passively derived antibodies to bovine respiratory syncytial virus (BRSV) and if there are differences in presence and/or subclass of these antibodies between calves fed different colostrum replacement products, 17 Holstein calves were fed 150 g of IgG in either a sprayed-dried colostrum-based (CR; = 8) or a plasma-based colostrum replacement product (PR; = 9) within 6 h of birth. Venous blood and nasal secretions obtained before feeding and at 24 h of age were assayed for total IgG (serum) by radial immunodiffusion and for BRSV-specific total IgG, IgG-1, and IgG-2 by indirect enzyme-linked immunosorbent assay (ELISA). Calves that were fed a CR had higher concentrations of BRSV-specific IgG and IgG-1 in their serum and nasal secretions compared to calves fed product PR; calves fed the PR had higher levels of serum BRSV-specific IgG-2. The only subclass of antibodies detected in nasal secretions was IgG-1. Re-secretion of passive IgG with neutralizing activity, onto the nasal mucosa could contribute to BRSV-associated disease-sparing observed in the laboratory and in the field. Use of PR will result in lower nasal antibodies since IgG-2 is not re-secreted.
ISSN:0008-5286